These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34220733)

  • 1. The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm
    Hassett DJ; Kovall RA; Schurr MJ; Kotagiri N; Kumari H; Satish L
    Front Microbiol; 2021; 12():639362. PubMed ID: 34220733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AB569, a Novel, Topical Bactericidal Gel Formulation, Kills Pseudomonas aeruginosa and Promotes Wound Healing in a Murine Model of Burn Wound Infection.
    Barry A; Panmanee W; Hassett DJ; Satish L
    Infect Immun; 2021 Oct; 89(11):e0033621. PubMed ID: 34424744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AB569, a nontoxic chemical tandem that kills major human pathogenic bacteria.
    McDaniel CT; Panmanee W; Winsor GL; Gill E; Bertelli C; Schurr MJ; Dongare P; Paul AT; Ko SB; Lau GW; Dasgupta N; Bogue AL; Miller WE; Mortensen JE; Haslam DB; Dexheimer P; Muruve DA; Aronow BJ; Forbes MDE; Danilczuk M; Brinkman FSL; Hancock REW; Meyer TJ; Hassett DJ
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4921-4930. PubMed ID: 32071223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Bactericidal Drug Effective Against Gram-Positive and Gram-Negative Pathogenic Bacteria: Easy as AB569.
    Hassett DJ; Meyer TJ
    DNA Cell Biol; 2020 Sep; 39(9):1473-1477. PubMed ID: 32721230
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against
    Rineh A; Soren O; McEwan T; Ravikumar V; Poh WH; Azamifar F; Naimi-Jamal MR; Cheung CY; Elliott AG; Zuegg J; Blaskovich MAT; Cooper MA; Dolange V; Christodoulides M; Cook GM; Rice SA; Faust SN; Webb JS; Kelso MJ
    ACS Infect Dis; 2020 Jun; 6(6):1460-1479. PubMed ID: 32329596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-sigma factor MucA of Pseudomonas aeruginosa: Dramatic differences of a mucA22 vs. a ΔmucA mutant in anaerobic acidified nitrite sensitivity of planktonic and biofilm bacteria in vitro and during chronic murine lung infection.
    Panmanee W; Su S; Schurr MJ; Lau GW; Zhu X; Ren Z; McDaniel CT; Lu LJ; Ohman DE; Muruve DA; Panos RJ; Yu HD; Thompson TB; Tseng BS; Hassett DJ
    PLoS One; 2019; 14(6):e0216401. PubMed ID: 31158231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loci Encoding Compounds Potentially Active against Drug-Resistant Pathogens amidst a Decreasing Pool of Novel Antibiotics.
    Basalla J; Chatterjee P; Burgess E; Khan M; Verbrugge E; Wiegmann DD; LiPuma JJ; Wildschutte H
    Appl Environ Microbiol; 2019 Dec; 85(23):. PubMed ID: 31540982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary tract infections caused by Pseudomonas aeruginosa among children in Southern Poland: Virulence factors and antibiotic resistance.
    Pobiega M; Maciag J; Pomorska-Wesolowska M; Chmielarczyk A; Romaniszyn D; Ziolkowski G; Heczko PB; Wojkowska-Mach J; Bulanda M
    J Pediatr Urol; 2016 Feb; 12(1):36.e1-6. PubMed ID: 26320394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis.
    Chernish RN; Aaron SD
    Curr Opin Pulm Med; 2003 Nov; 9(6):509-15. PubMed ID: 14534404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
    Rutter WC; Burgess DR; Burgess DS
    Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP; Brownlee KG; Denton M; Peckham DG
    Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
    Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
    Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.